Skip to content
GenoLensGenoLens

ANO10

Chr 3p22.1-p21.33

anoctamin 10

Aliases:
FLJ10375, MGC47890, SCAR10
MANE:
ENST00000292246.8

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Ataxia and cerebellar anomalies - narrow panel

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary ataxia

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary ataxia with onset in adulthood

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Mitochondrial disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Possible mitochondrial disorder - nuclear genes

    BIALLELIC, autosomal or pseudoautosomal

+2 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • autosomal recessive spinocerebellar ataxia 10

    0.79
  • Adult-onset autosomal recessive cerebellar ataxia

    0.73
  • Dorfman-Chanarin disease

    0.46
  • attention deficit-hyperactivity disorder

    0.37
  • COVID-19

    0.37
  • autosomal recessive cerebellar ataxia

    0.35
  • Abnormal central motor function

    0.34
  • major depressive disorder

    0.33
  • risk-taking behaviour

    0.30
  • post-traumatic stress disorder

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Anoctamin-10

Does not exhibit calcium-activated chloride channel (CaCC) activity. Can inhibit the activity of ANO1

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.